HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

ramucirumab

anti-VEGFR-2 mAb for treating cancer
Also Known As:
IMC 1121B; IMC-1121B; IMC1121B
Networked: 86 relevant articles (15 outcomes, 47 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Schwartz, Jonathan D: 9 articles (09/2015 - 12/2013)
2. Abdel-Rahman, Omar: 5 articles (11/2015 - 01/2014)
3. Chau, Ian: 5 articles (11/2015 - 01/2014)
4. Joshi, Adarsh: 5 articles (09/2015 - 12/2013)
5. ElHalawani, Hesham: 4 articles (11/2015 - 01/2014)
6. Hozak, Rebecca R: 4 articles (09/2015 - 12/2013)
7. Gao, Ling: 4 articles (07/2015 - 01/2014)
8. Yurasov, Sergey: 4 articles (03/2015 - 11/2012)
9. Aprile, Giuseppe: 4 articles (01/2014 - 05/2013)
10. Yang, Ling: 3 articles (09/2015 - 10/2014)

Related Diseases

1. Neoplasms (Cancer)
2. Stomach Neoplasms (Stomach Cancer)
3. Adenocarcinoma
4. Colorectal Neoplasms (Colorectal Cancer)
5. Breast Neoplasms (Breast Cancer)

Related Drugs and Biologics

1. Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)
2. Vascular Endothelial Growth Factor Receptors (VEGF Receptors)
3. Paclitaxel (Taxol)
4. docetaxel (Taxotere)
5. capecitabine (Xeloda)
6. trastuzumab (Herceptin)
7. sorafenib (BAY 43-9006)
8. Cisplatin (Platino)
9. Biological Markers (Surrogate Marker)
10. bevacizumab

Related Therapies and Procedures

1. Drug Therapy (Chemotherapy)
2. Biological Therapy
3. Heterologous Transplantation (Xenotransplantation)
4. Castration
5. Drug-Eluting Stents